Immunogenicity and Safety of Pandemic Influenza Vaccine in Healthy Adults
Clinical trial NCT01640691 · COMPLETED
Trial details
- NCT number
- NCT01640691
- Sponsor
- Adimmune Corporation
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-10
- Primary completion
- 2013-01-02
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.